Abstract
Much of the gradual decline in HIV incidence over the past decade has been attributed to expanded coverage of antiretroviral therapy (ART). An increasing proportion of people living with HIV are on ART and are virally suppressed, therefore unable to transmit the virus to their partners. Universal testing and treatment has been proposed as a key strategy to increase ART coverage in an attempt to achieve steeper reductions in HIV incidence.1 This strategy involves wide-scale delivery of HIV testing at the community level, accompanied by effective linkage to care and support for ART adherence.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
